AFMD - Oncologists comments out of AACR plenary presentation seems out of character in terms of giddiness. The few oncologist friends that I know are typically subdued and fearful of being positive.
concluding paragraph - “Never before in mankind have we seen this approach, really leading to pretty staggering results,” Timothy Yap, MBBS, PhD, FRCP, a medical oncologist and associate director of translational research in the Institute for Personalized Cancer Therapy at the University of Texas MD Anderson Cancer Center, said. “Everyone can see for themselves how impressive these results are. In addition to that, the actual tolerability profile is truly excellent with no instances of cytokine release syndrome, no neurotoxicity, no GVHD. Truly, truly impressive.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.